伤口世界
  • 首页
  • 病情图文
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
      • 动脉性溃疡
      • 静脉性溃疡
      • 放射性溃疡
    • 烧伤
    • 创伤
    • 少见伤口
    • 祛疤止痒
    • 皮肤病
  • 医师讲座
  • 名医介绍
    专业服务
    • 糖尿病足
    • 压疮
    • 造口
    • 溃疡
    • 烧伤
    蔡道章院长

    Custom Mod Mega1

    主任医师、教授、博导,南方医科大学第三附属医院(广东省骨科医院)院长

    • 中德骨科伤口管理学校校长
    • 广东省骨科研究院运动医学研究所所长
    • 广东省内运动医学专业唯一的博士研究生导师
    • 美国哈弗大学医学院骨科访问学者
    • 专业特长处于省内领先、国内或国际先进水平以上
    • 2018年获得“国之名医卓越建树”荣誉称号
    • 2017年被评为全国卫生计生系统先进工作者、广东省医学领军人才
    • 中国医师协会运动医师分会副会长
    • STCOT中国部运动医学分会副主任委员
    • 广东省医学会关节外科分会主任委员
    • 广东省医学会运动医学会分会名誉主任委员
    • 独立承担过国家“863”课题,主持过10余项省、部级科研项目
    • 多份专业杂志编委
  • 文献精选
    伤口分类
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
    • 烧伤
    • 更多关于伤口信息
    最新文献
    • Relationship between liver fat, pancreatic fat, and new-onset type 2 diabetes mellitus in patients with metabolic dysfunction-associated fatty liver disease 2026-05-21 00:00

      Huanjia Qu1  · Lingling Zhou1  · Dong Tang2  · Qiuling Zhang1  · Pu Yang3  · Boyi Yang3  · Junping Shi4

      Received: 25 December 2024 / Accepted: 22 March 2025 / Published online: 19 April 2025 © The Author(s) 2025

      Abstract

      Purpose Type 2 diabetes mellitus (T2DM) is associated with ectopic fat deposition, especially in the liver and pancreas.Therefore, this study aimed to evaluate the relationship between liver fat fraction (LFF), pancreatic fat fraction (PFF), and new-onset T2DM in metabolic dysfunction-associated fatty liver disease (MAFLD) by magnetic resonance imaging (MRI).

      Methods This is a retrospective study of patients with MAFLD who underwent abdominal MRI between 2022 and July 2024. LFF and PFF were measured using an axial multi-echo Dixon-based sequence. All participants underwent routine medical history, anthropometric measurements, and laboratory tests. Multivariable stepwise selection models were con-structed to predict PFF and T2DM status based on variables of clinical interest.

      Results This study included 80 MAFLD patients with 40 untreated new-onset T2DM and 40 non-T2DM controls. LFF, PFF, and homeostasis model assessment of insulin resistance (HOMA-IR) index were higher in the T2DM group than in the control group. In the new-onset T2DM group, PFF was linearly positively correlated with LFF (rs=0.321, P=0.04) and HOMA-IR (rs=0.350, P=0.03). After adjustment for several metabolic variables, PFF remained an independent risk factor for incident T2DM in MAFLD patients (all P<0.05). The area under the receiver operating characteristic curve for PFF and LFF to predict T2DM was 0.889 and 0.633 (P<0.001 and P=0.03), respectively.

      Conclusion In MAFLD patients, PFF, and LFF play a prominent role in new-onset T2DM with high predictive and diag-nostic value.

      Keywords Metabolic dysfunction-associated fatty liver disease · Type 2 diabetes mellitus · Liver fat fraction ·Pancreatic fat fraction · Ectopic fat deposition · MRI

    • Switching patterns of GLP-1 receptor agonists from 2018 to 2025 in the largest private healthcare network in Poland 2026-05-20 00:00

      Krzysztof Łupina1  · Artur Dziewierz2,3  · Jakub Janczura1  · Zbigniew Siudak1,4

      Received: 6 March 2026 / Accepted: 26 April 2026

      © The Author(s) 2026

      Abstract

      Aims To characterize switching among GLP-1 receptor agonists (GLP-1 RAs) in a large private-sector cohort in Poland and to quantify therapy- and patient-level associations with switching while accounting for switching opportunity and calendar-time dynamics.

      Methods We conducted a retrospective analysis of GLP-1 RA prescription records from the LUX MED network (2018–2025). Switching was defined as any change in agent between consecutive prescriptions. Patients with more than one pre-scription were included (n=42,423). The primary analysis used a transition-level discrete-time hazard model in which each prescription-to-prescription interval contributed one observation, and the outcome was switching at that interval. Current-therapy contrasts were reported relative to subcutaneous semaglutide. Sensitivity analyses examined alternative temporal parameterizations and additional adjustment for elapsed time.

      Results Overall, 29.7% of patients switched at least once and 14.3% switched two or more times. In the transition-level analysis, 12,620 patients contributed 27,095 transitions. After adjustment for opportunity and calendar time, liraglutide was associated with substantially lower odds of switching compared with subcutaneous semaglutide (OR, 0.02; 95% CI, 0.01–0.03), whereas oral semaglutide (OR, 1.30; 95% CI, 0.78–2.17) and dulaglutide (OR, 1.70; 95% CI, 0.95–3.04) did not differ significantly. Temporal analyses revealed peaks consistent with episodic substitution and accelerated tirzepatide uptake after market entry. The principal associations remained directionally consistent in sensitivity analyses.

      Conclusions Switching among GLP-1 RAs is common and time-dependent. Time-aware modelling identified therapy-spe-cific switching patterns and pronounced temporal variation; reasons for switching remain unmeasured, and the observed associations should be interpreted as hypothesis-generating.

      Keywords Glucagon-like peptide-1 receptor agonists · Tirzepatide · Treatment switching · Real-world evidence · Private healthcare · Obesity

  • 互动快递
  • 首页
  • 病情图文
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
      • 动脉性溃疡
      • 静脉性溃疡
      • 放射性溃疡
    • 烧伤
    • 创伤
    • 少见伤口
    • 祛疤止痒
    • 皮肤病
  • 医师讲座
  • 名医介绍
    • 专业服务
      • 糖尿病足
      • 压疮
      • 造口
      • 溃疡
      • 烧伤
    • 蔡道章院长
  • 文献精选
    • 伤口分类
      • 糖尿病足
      • 压疮
      • 感染伤口
      • 造口
      • 溃疡
      • 烧伤
      • 更多关于伤口信息
    • 最新文献
  • 互动快递
  • 当前位置: 
  • 首页
  • 名医介绍
  • 李孝建

李孝建

  • 字号 + –
26 8月 2019
  • 1
  • 2
  • 3
  • 4
  • 5
Author :   伤口世界
李孝建

专长:重症烧伤救治。广东省医学会烧伤科分会主任委员、广东省医疗行业协会伤口管理分会副主委。

广东红十字会医院烧伤整形科主任医师,博士研究生导师。烧伤科大主任、烧伤ICU主任。

Latest from  伤口世界

  • Relationship between liver fat, pancreatic fat, and new-onset type 2 diabetes mellitus in patients with metabolic dysfunction-associated fatty liver disease
  • Switching patterns of GLP-1 receptor agonists from 2018 to 2025 in the largest private healthcare network in Poland
  • 保湿润肤类产品应用指导 专家共识(2023版)
  • The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair
  • GLP-1 receptor agonists and coronary plaques regression in diabetic patients after acute coronary syndromes

Categories

  • 病情图文
  • 文献精选
  • 名医介绍
  • K2 Content
  • Relationship between liver fat, pancreatic fat, and new-onset type 2 diabetes mellitus in patients with metabolic dysfunction-associated fatty liver disease 2026-05-21 00:00

    Huanjia Qu1  · Lingling Zhou1  · Dong Tang2  · Qiuling Zhang1  · Pu Yang3  · Boyi Yang3  · Junping Shi4

    Received: 25 December 2024 / Accepted: 22 March 2025 / Published online: 19 April 2025 © The Author(s) 2025

    Abstract

    Purpose Type 2 diabetes mellitus (T2DM) is associated with ectopic fat deposition, especially in the liver and pancreas.Therefore, this study aimed to evaluate the relationship between liver fat fraction (LFF), pancreatic fat fraction (PFF), and new-onset T2DM in metabolic dysfunction-associated fatty liver disease (MAFLD) by magnetic resonance imaging (MRI).

    Methods This is a retrospective study of patients with MAFLD who underwent abdominal MRI between 2022 and July 2024. LFF and PFF were measured using an axial multi-echo Dixon-based sequence. All participants underwent routine medical history, anthropometric measurements, and laboratory tests. Multivariable stepwise selection models were con-structed to predict PFF and T2DM status based on variables of clinical interest.

    Results This study included 80 MAFLD patients with 40 untreated new-onset T2DM and 40 non-T2DM controls. LFF, PFF, and homeostasis model assessment of insulin resistance (HOMA-IR) index were higher in the T2DM group than in the control group. In the new-onset T2DM group, PFF was linearly positively correlated with LFF (rs=0.321, P=0.04) and HOMA-IR (rs=0.350, P=0.03). After adjustment for several metabolic variables, PFF remained an independent risk factor for incident T2DM in MAFLD patients (all P<0.05). The area under the receiver operating characteristic curve for PFF and LFF to predict T2DM was 0.889 and 0.633 (P<0.001 and P=0.03), respectively.

    Conclusion In MAFLD patients, PFF, and LFF play a prominent role in new-onset T2DM with high predictive and diag-nostic value.

    Keywords Metabolic dysfunction-associated fatty liver disease · Type 2 diabetes mellitus · Liver fat fraction ·Pancreatic fat fraction · Ectopic fat deposition · MRI

  • Switching patterns of GLP-1 receptor agonists from 2018 to 2025 in the largest private healthcare network in Poland 2026-05-20 00:00

    Krzysztof Łupina1  · Artur Dziewierz2,3  · Jakub Janczura1  · Zbigniew Siudak1,4

    Received: 6 March 2026 / Accepted: 26 April 2026

    © The Author(s) 2026

    Abstract

    Aims To characterize switching among GLP-1 receptor agonists (GLP-1 RAs) in a large private-sector cohort in Poland and to quantify therapy- and patient-level associations with switching while accounting for switching opportunity and calendar-time dynamics.

    Methods We conducted a retrospective analysis of GLP-1 RA prescription records from the LUX MED network (2018–2025). Switching was defined as any change in agent between consecutive prescriptions. Patients with more than one pre-scription were included (n=42,423). The primary analysis used a transition-level discrete-time hazard model in which each prescription-to-prescription interval contributed one observation, and the outcome was switching at that interval. Current-therapy contrasts were reported relative to subcutaneous semaglutide. Sensitivity analyses examined alternative temporal parameterizations and additional adjustment for elapsed time.

    Results Overall, 29.7% of patients switched at least once and 14.3% switched two or more times. In the transition-level analysis, 12,620 patients contributed 27,095 transitions. After adjustment for opportunity and calendar time, liraglutide was associated with substantially lower odds of switching compared with subcutaneous semaglutide (OR, 0.02; 95% CI, 0.01–0.03), whereas oral semaglutide (OR, 1.30; 95% CI, 0.78–2.17) and dulaglutide (OR, 1.70; 95% CI, 0.95–3.04) did not differ significantly. Temporal analyses revealed peaks consistent with episodic substitution and accelerated tirzepatide uptake after market entry. The principal associations remained directionally consistent in sensitivity analyses.

    Conclusions Switching among GLP-1 RAs is common and time-dependent. Time-aware modelling identified therapy-spe-cific switching patterns and pronounced temporal variation; reasons for switching remain unmeasured, and the observed associations should be interpreted as hypothesis-generating.

    Keywords Glucagon-like peptide-1 receptor agonists · Tirzepatide · Treatment switching · Real-world evidence · Private healthcare · Obesity

  • 保湿润肤类产品应用指导 专家共识(2023版) 2026-05-19 00:00

    中国医师协会皮肤科医师分会

    通信作者:郝飞,Email:该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。;高兴华,Email:该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

    【摘要】 应用保湿润肤类产品是保护或修护皮肤屏障、维护皮肤健康和防治皮肤病的重要手段。为规范及合理应用保湿润肤类产品,中国医师协会皮肤科医师分会组织国内有关专家,结合国内外研究现状,就保湿润肤类产品的功效、成分选择、应用指征、使用法、不良反应及注意事项等深入讨论并达成此共识。

    【关键词】 皮肤;保湿润肤类产品;合理应用;皮肤屏障;专家共识

    DOI:10.35541/cjd.20230133

    Guidance on application of moisturizers and emollients: an expert consensus(2023)

    China Dermatologist Association

    Corresponding authors: Hao Fei, Email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。; Gao Xinghua, Email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

    【Abstract】 The application of moisturizers and emollients is an important method for protecting or repairing skin barriers, maintaining skin health, and coping with skin diseases. In order to standardize and rationalize the application of moisturizers and emollients, the China Dermatologist Association convened Chinese experts in this field to conduct sessions of in⁃depth discussions based on up⁃to⁃date Chinese and international research outcomes, and reached a consensus on the efficacy, composition selection, application indications, application methods and adverse reactions of moisturizers and emollients, as well as considerations during their use.

    【Key words】

    Skin; Moisturizers and emollients; Rational application; Skin barriers; Expert consensus

    DOI: 10.35541/cjd.20230133

        皮肤屏障功能维持着机体内环境稳定[1] 。遗传基因异常、生理性衰退及各种疾病等均可破坏皮肤完整性,导致屏障功能障碍,进一步影响皮肤健康乃至疾病的发生和发展[2] 。因此,使用保湿润肤类产品成为保护和修复皮肤屏障的重要措施。为规范及合理应用保湿润肤类产品,中国医师协会皮肤科医师分会组织国内有关专家,结合国内外研究现状,就保湿润肤类产品的功效、成分选择、应用指征、使用方法、不良反应及注意事项等深入讨论并达成应用指导的专家共识。

        本共识文献检索自Medline、PubMed、Cochrane协作网、中国知网、万方医学网等数据库,关键词包括 但 不 限 于 :moisturizer、emollient、skincare、skinbarrier、保湿润肤类产品、保湿剂、润肤剂、护肤品、皮肤屏障、天然保湿因子、特应性皮炎(atopicdermatitis,AD)、玫瑰痤疮、敏感性皮肤、经表皮失水率等,检索起始时间不限,大部分参考文献为2010年后最新发表。文中近30条重要结论均经过专家组Delphi问询法论证。

Popular Tags

  • 糖尿病足
  • 祛疤止痒
  • 皮肤病
  • 造口
  • 溃疡
  • 动脉性溃疡
  • 静脉性溃疡
  • 放射性溃疡
  • 烧伤
  • 创伤

伤口世界平台生态圈,以“关爱人间所有伤口患者”为愿景,连接、整合和拓展线上和线下的管理慢性伤口的资源,倡导远程、就近和居家管理慢性伤口,解决伤口专家的碎片化时间的价值创造、诊疗经验的裂变复制、和患者的就近、居家和低成本管理慢性伤口的问题。

 

消息订阅

关注伤口世界动态,了解专业领域最新科技
Copyright © 2026 中诺医疗. All Rights Reserved
皖ICP备19014494号-1

学术会议

2019广东省医疗行业协会伤口管理分会年会

扫一扫了解详情:

 

  • 2019年6月15日 中国广州
  • 主办单位:广东省医疗行业协会伤口管理分会

伤口世界提示

任何关于疾病的建议都不能替代执业医师的面对面诊断。所有门诊时间仅供参考,最终以医院当日公布为准。

网友、医生言论仅代表其个人观点,不代表本站同意其说法,请谨慎参阅,本站不承担由此引起的法律责任。